본문 바로가기
KERD
논문KCI 등재

Clinical meaning of sarcopenia in patients undergoing endoscopic treatment

Yu Takahashi|Yosuke Tsuji|Nobutake Yamamichi|Naomi Kakushima|Mitsuhiro Fujishiro|Hikaru Kuribara|Ryohei Miyata|Hideki Nakagawa|Yuko Miura|Hiroya Mizutani|Daisuke Ohki|Seiichi Yakabi|Hiroyuki Hisada|Kaori Oshio|Satoru Mizutani|Rina Cho|Nobuyuki Sakuma|Yoshiki Sakaguchi
대한소화기내시경학회 (The Korean Society Of Gastrointestinal Endoscopy)|2024.07|Clinical Endoscopy|제57권 제4호|pp. 446-453|DOI 10.5946/ce.2023.193

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

AgedSarcopeniaNeoplasmsPrognosisEndoscopic submucosal dissection
주제분류내과학

초록

With increasing global life expectancy, the significance of geriatric assessment parameters has increased. Sarcopenia is a crucial assessment parameter and is defined as the age-related loss of muscle mass and strength. Sarcopenia is widely acknowledged as a risk factor for postoperative complications in diverse advanced malignancies and has a detrimental effect on the long-term prognosis. While most studies have primarily concentrated on the correlation between sarcopenia and advanced cancer, more recent investigations have focused on the relationship between sarcopenia and early-stage cancer. Endoscopic submucosal dissection (ESD), which is less invasive than surgical intervention, is extensively employed in the management of early-stage cancer, although it is associated with complications such as bleeding and perforation. In recent years, several reports have revealed the adverse consequences of sarcopenia in patients with early-stage cancer undergoing ESD. This literature review briefly summarizes the recent studies on the association between sarcopenia and ESD.

Abstract

With increasing global life expectancy, the significance of geriatric assessment parameters has increased. Sarcopenia is a crucial assessment parameter and is defined as the age-related loss of muscle mass and strength. Sarcopenia is widely acknowledged as a risk factor for postoperative complications in diverse advanced malignancies and has a detrimental effect on the long-term prognosis. While most studies have primarily concentrated on the correlation between sarcopenia and advanced cancer, more recent investigations have focused on the relationship between sarcopenia and early-stage cancer. Endoscopic submucosal dissection (ESD), which is less invasive than surgical intervention, is extensively employed in the management of early-stage cancer, although it is associated with complications such as bleeding and perforation. In recent years, several reports have revealed the adverse consequences of sarcopenia in patients with early-stage cancer undergoing ESD. This literature review briefly summarizes the recent studies on the association between sarcopenia and ESD.

참고문헌 (45)

  1. World Population Prospects 2022: summary of results, "Population Division, United Nations", Population Division, United Nations, ~ (2022)
  2. Cruz-Jentoft AJ, "Sarcopenia : revised European consensus on definition and diagnosis", Age Ageing, 48, pp.16~31 (2019)
  3. Chen LK, "Asian Working Group for Sarcopenia : 2019 consensus update on sarcopenia diagnosis and treatment", J Am Med Dir Assoc, 21, pp.300~307 (2020)
  4. Yang Z, "Predictive value of preoperative sarcopenia in patients with gastric cancer : a meta-analysis and systematic review", J Gastrointest Surg, 22, pp.1890~1902 (2018)
  5. O’Connell RM, "Sarcopaenia, obesity, sarcopaenic obesity and outcomes following hepatic resection for colorectal liver metastases : a systematic review and meta-analysis", HPB(Oxford), 24, pp.1844~1853 (2022)
  6. Fang P, "The prognostic value of sarcopenia in oesophageal cancer : a systematic review and meta-analysis", J Cachexia Sarcopenia Muscle, 14, pp.3~16 (2023)
  7. Fukuda Y, "Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy", Gastric Cancer, 19, pp.986~993 (2016)
  8. Thormann M, "Low skeletal muscle mass and post-operative complications after surgery for liver malignancies : a meta-analysis", Langenbecks Arch Surg, 407, pp.1369~1379 (2022)
  9. Cleasby ME, "Insulin resistance and sarcopenia : mechanistic links between common co-morbidities", J Endocrinol, 229, pp.R67~R81 (2016)
  10. Tsuji M, "Sarcopenia and risk of infection in adult heart transplant recipients in Japan", ESC Heart Fail, 9, pp.1413~1423 (2022)
  11. Braun S, "The link between the metabolic syndrome and cancer", Int J Biol Sci, 7, pp.1003~1015 (2011)
  12. Yamamoto K, "Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer", Gastric Cancer, 20, pp.913~918 (2017)
  13. Hisada H, "Endoscopic treatment of superficial gastric cancer : present status and future", Curr Oncol, 29, pp.4678~4688 (2022)
  14. Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer(second edition)", Dig Endosc, 33, pp.4~20 (2021)
  15. Pimentel-Nunes P, "Endoscopic submucosal dissection for superficial gastrointestinal lesions : European Society of Gastrointestinal Endoscopy(ESGE)Guideline-Update 2022", Endoscopy, 54, pp.591~622 (2022)
  16. Tanaka S, "Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection", endoscopic mucosal resection, 2020, pp.32, 219~239
  17. Liu Q, "Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer : a systematic review and meta-analysis", Int J Surg, 73, pp.28~41 (2020)
  18. Nakamura F, "Short-term prospective questionnaire study of early postoperative quality of life after colorectal endoscopic submucosal dissection", Dig Dis Sci, 62, pp.3325~3335 (2017)
  19. Gweon TG, "Management of complications related to colorectal endoscopic submucosal dissection", Clin Endosc, 56, pp.423~432 (2023)
  20. Saito I, "Complications related to gastric endoscopic submucosal dissection and their managements", Clin Endosc, 47, pp.398~403 (2014)
  21. Toya Y, "Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 85 years : EGC-2 model", J Cancer Res Clin Oncol, 149, pp.1521~1530 (2023)
  22. Chang JW, "Long-term outcomes and prognostic factors of superficial esophageal cancer in patients aged ≥ 65 years", Front Med(Lausanne), 8, pp.722141~ (2022)
  23. Kato M, "Geriatric nutritional risk index as a prognostic indicator in elderly patients with early colorectal cancer undergoing endoscopic submucosal dissection", Dig Endosc, 34, pp.569~578 (2022)
  24. Rosenberg IH, "Sarcopenia : origins and clinical relevance", J Nutr, 127(5 Suppl), pp.990~ (1997)
  25. Cruz-Jentoft AJ, "Sarcopenia : European consensus on definition and diagnosis : report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39, pp.412~423 (2010)
  26. Chen LK, "Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia", J Am Med Dir Assoc, 15, pp.95~101 (2014)
  27. Falcon LJ, "Sarcopenia and the new ICD-10-CM code : screening, staging, and diagnosis considerations", Fed Pract, 34, pp.24~32 (2017)
  28. Schaap LA, "Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures : the Longitudinal Aging Study Amsterdam", J Gerontol A Biol Sci Med Sci, 73, pp.1199~1204 (2018)
  29. Hamaguchi Y, "Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation", Transplantation, 101, pp.565~574 (2017)
  30. Arao M, "Skeletal muscle depletion : a risk factor for pneumonia following gastric endoscopic submucosal dissection in elderly patients", Dig Dis, 39, pp.435~443 (2021)
  31. Kim GH, "Impact of comorbidities, sarcopenia, and nutritional status on the long-term outcomes after endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 80 years", Cancers(Basel), 13, pp.3598~ (2021)
  32. Hisada H, "The impact of sarcopenia on short-and long-term outcomes of endoscopic submucosal dissection for early gastric cancer", J Gastroenterol, 57, pp.952~961 (2022)
  33. Ito N, "Relationship between psoas muscle index and long-term survival in older patients aged ≥ 80 years after endoscopic submucosal dissection for gastric cancer", Int J Clin Oncol, 27, pp.729~738 (2022)
  34. Ito N, "Scoring system for predicting the prognosis of elderly gastric cancer patients after endoscopic submucosal dissection", Dig Endosc, 35, pp.67~76 (2023)
  35. Hisada H, "The impact of sarcopenia on adverse events associated with gastric endoscopic submucosal dissection", Surg Endosc, 36, pp.6387~6395 (2022)
  36. Zhang FM, "Impact of sarcopenia on clinical outcomes of patients with stage I gastric cancer after radical gastrectomy : a prospective cohort study", Eur J Surg Oncol, 48, pp.541~547 (2022)
  37. He X, "Prevalence and factors influencing sarcopenia among community-dwelling older adults using the Asian Working Group for Sarcopenia Definition", Clin Interv Aging, 17, pp.1707~1727 (2022)
  38. Japanese Gastric Cancer Association, "Japanese Gastric Cancer Treatment Guidelines 2021(6th edition)", Gastric Cancer, 26, pp.1~25 (2023)
  39. Chang JW, "Long-term outcomes and prognostic factors of endoscopic submucosal dissection for early gastric cancer in patients aged ≥75 years", Cancers(Basel), 12, pp.3222~ (2020)
  40. Waki K, "Long-term outcomes after endoscopic resection for late-elderly patients with early gastric cancer", Gastrointest Endosc, 95, pp.873~883 (2022)
  41. Rom H, "Sarcopenia as a predictor of survival in patients with pancreatic adenocarcinoma after pancreatectomy", Ann Surg Oncol, 29, pp.1553~1563 (2022)
  42. Ishida T, "Quantity and quality of skeletal muscle as an important predictor of clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy", Ann Surg Oncol, 28, pp.7185~7195 (2021)
  43. Tsukuma H, "Prospective study of"early"gastric cancer", Int J Cancer, 31, pp.421~426 (1983)
  44. Goto S, "Efficacy and safety of colorectal endoscopic submucosal dissection in patients with sarcopenia", Surg Endosc, 35, pp.5489~5496 (2021)
  45. Kudo S, "Influence of esophageal endoscopic submucosal dissection on the changes of energy metabolism during the perioperative period", Cancers(Basel), 14, pp.2015~ (2022)

관련 논문AI추천

Prevalence and associated risk of advanced colorectal neoplasia in adults with sarcopeniaKyeong Ok Kim, Min Cheol Kim, Min Kyu Kang대한내과학회 · The Korean Journal of Internal Medicine2022 · 제37권 제2호Influence of sarcopenia on clinical outcomes in peptic ulcer bleeding: a retrospective single-center analysis in KoreaAh Young Lee, Hyun Tak Lee, Ji Hoon Yu, Jun-young Seo, Seok Ki Jang대한소화기내시경학회 · Clinical Endoscopy2025 · 제58권 제3호Association between Colorectal Adenoma and Hand Grip Strength in the Elderly공미희, 김예지, 김현주, 문지현, 오윤환대한골대사학회 · 대한골대사학회지2019 · 제26권 제3호Computed-Tomography-Determined Sarcopenia is a Useful Imaging Biomarker for Predicting Postoperative Outcomes in Elderly Colorectal Cancer PatientsFeng Gao, Guotian Ruan, Hailun Xie, Jiaan Kuang, Jialiang Gan, Ling Yan, Shuangyi Tang, Yizhen Gong대한암학회 · Cancer Research and Treatment2020 · 제52권 제3호Efficacy and Safety of Endoscopic Submucosal Dissection for Early Gastric Cancer in Patients with Comorbid Diseases김경미, 김재준, 민병훈, 박철근, 손희정, 이종철, 이준행, 이풍렬, Beom Jin Kim, Tae Hoon Chang거트앤리버 소화기연관학회협의회 · Gut and Liver2010 · 제4권 제2호Sarcopenia in the era of aging populations: its clinical implications for peptic ulcer bleedingHiroyuki Hisada, Mitsuhiro Fujishiro, Yosuke Tsuji대한소화기내시경학회 · Clinical Endoscopy2025 · 제58권 제3호

이 간행물의 다른 논문 (21건)

Potassium-competitive acid blocker-associated gastric mucosal lesionsKimitoshi Kubo, Noriko Kimura, Mototsugu Katopp. 417-423Colon stenting as a bridge to surgery in obstructive colorectal cancer managementHan Hee Lee, Dong Hyun Kimpp. 424-433Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy for pancreatic cystic lesions: current status and future prospectsDamien Meng Yew Tan, Samuel Jun Ming Lim, Clement Chun Ho Wupp. 434-445Systematic review of self-assembling peptides as topical agents for treatment and prevention of gastrointestinal bleedingPaul Bălănescu, Radu Bogdan Mateescu, Theodor Voiosu, Sergiu Văduva, Victor Drăgan, Monica State, Andrei Voiosupp. 454-465Is your endoscopist qualified enough to detect Helicobacter pylori-naive status?Sun-Young Leepp. 466-467
원문 보기